We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

527 hedge funds and large institutions have $16B invested in Abiomed Inc in 2018 Q2 according to their latest regulatory filings, with 153 funds opening new positions, 157 increasing their positions, 171 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

428% more first-time investments, than exits

New positions opened: 153 | Existing positions closed: 29

40% more funds holding in top 10

Funds holding in top 10: 15 → 21 (+6)

40% more capital invested

Capital invested by funds: $11.5B → $16B (+$4.55B)

30% more funds holding

Funds holding: 405 → 527 (+122)

8% less repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 171

21% less call options, than puts

Call options by funds: $167M | Put options by funds: $212M

Holders
527
Holders Change
+122
Holders Change %
+30.12%
% of All Funds
12.07%
Holding in Top 10
21
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+40%
% of All Funds
0.48%
New
153
Increased
157
Reduced
171
Closed
29
Calls
$167M
Puts
$212M
Net Calls
-$45.4M
Net Calls Change
-$39.3M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$297M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$210M
3
State Street
State Street
Massachusetts
+$158M
4
Renaissance Technologies
Renaissance Technologies
New York
+$146M
5
Two Sigma Investments
Two Sigma Investments
New York
+$138M

Top Sellers

1
BlackRock
BlackRock
New York
-$315M
2
Winslow Capital Management
Winslow Capital Management
Minnesota
-$284M
3
PAI
Palo Alto Investors
California
-$165M
4
William Blair Investment Management
William Blair Investment Management
Illinois
-$154M
5
American Century Companies
American Century Companies
Missouri
-$136M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
401
Cortina Asset Management
Wisconsin
$382K – – –
BTS
402
BB&T Securities
Virginia
$379K -$138K -382 -29%
SWM
403
SeaCrest Wealth Management
New York
$378K -$18.1K -50 -5%
N
404
Nuveen
North Carolina
$378K +$334K +923 New
SIA
405
Sit Investment Associates
Minnesota
$368K +$326K +900 New
MCM
406
Marathon Capital Management
Maryland
$367K -$36.6K -101 -10%
GH
407
GAM Holding
Switzerland
$364K +$323K +891 New
WP
408
WealthSource Partners
California
$363K +$63.4K +175 +25%
IRF
409
IBM Retirement Fund
New York
$331K -$34.8K -96 -11%
PI
410
PineBridge Investments
New York
$330K +$293K +808 New
AIP
411
Ameritas Investment Partners
Nebraska
$327K -$4.26M -11,754 -94%
BWM
412
Buckley Wealth Management
Nevada
$327K – – –
KRSITF
413
Kentucky Retirement Systems Insurance Trust Fund
Kentucky
$326K +$288K +796 New
Qube Research & Technologies (QRT)
414
Qube Research & Technologies (QRT)
United Kingdom
$326K +$289K +798 New
BOH
415
Bank of Hawaii
Hawaii
$316K +$280K +773 New
IC
416
Intersect Capital
California
$301K – – –
PFM
417
Parsec Financial Management
North Carolina
$290K – – –
V
418
Veritable
Delaware
$275K +$244K +673 New
SS
419
Simplicity Solutions
Minnesota
$267K +$237K +653 New
TAM
420
Tiverton Asset Management
Delaware
$261K +$231K +637 New
FGAM
421
Financial Gravity Asset Management
Texas
$260K +$245K +675 +4,821%
UCFA
422
United Capital Financial Advisors
Texas
$254K +$225K +622 New
GWM
423
Geneos Wealth Management
Colorado
$245K – – –
BC
424
Burney Company
Virginia
$245K +$217K +600 New
CCA
425
Conestoga Capital Advisors
Pennsylvania
$245K +$217K +600 New
15 16
17
18 19

ABMD Hedge Fund Activity: Q2 2018 in Review

527 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2018, worth a combined $16B — up 40% from $11.5B a quarter earlier.

Buyers outnumbered sellers: 153 funds opened new ABMD positions and 29 closed out — a net gain of 124 holders — while 157 added to existing stakes and 171 trimmed.

The largest buyer was Vanguard Group, adding an estimated $297M. The largest seller was BlackRock, cutting an estimated $315M.

  • 527 institutional investors held Abiomed Inc (ABMD) as of Q2 2018, up from 405 in Q1 2018.
  • Funds reported $16B of Abiomed Inc stock for Q2 2018, up 40% quarter-over-quarter.
  • 153 funds opened new Abiomed Inc positions in Q2 2018 and 29 closed out, a net change of +124 holders.
  • The largest Abiomed Inc buyer in Q2 2018 was Vanguard Group, an estimated $297M added.
  • The largest Abiomed Inc seller in Q2 2018 was BlackRock, an estimated $315M sold.

Based on aggregated 13F filings for Q2 2018.